ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Hot Features

Registration Strip Icon for discussion Registrieren Sie sich, um in unseren aktiven Foren mit gleichgesinnten Anlegern zu diskutieren.

CRDF Cardiff Oncology Inc

4,17
0,00 (0,00%)
Vor Marktöffnung
Zuletzt aktualisiert: 11:26:01
Verzögert um 15 Minuten
Name Symbol Markt Aktientyp
Cardiff Oncology Inc CRDF NASDAQ Common Stock
  Änderung Änderung % Aktuell Zeit
0,00 0,00% 4,17 11:26:01
Handelsbeginn Niedrig Hoch Schlusskurs Handelsende
4,17
more quote information »

Aktuelle News

Datum Zeit Quelle Überschrift
08.4.202422:05GLOBECardiff Oncology Presents Novel Preclinical Data at AACR..
08.3.202400:40EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08.3.202400:40EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08.3.202400:39EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08.3.202400:39EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06.3.202422:05GLOBECardiff Oncology Announces Upcoming Presentations at the..
29.2.202422:07GLOBECardiff Oncology Reports Fourth Quarter and Full Year 2023..
29.2.202422:06GLOBECardiff Oncology Provides Clinical Update on Phase 2..
29.2.202422:05GLOBECardiff Oncology Announces First Patient Dosed in Randomized..
29.2.202422:00EDGAR2Form 10-K - Annual report [Section 13 and 15(d), not S-K..
26.2.202414:00GLOBECardiff Oncology to Present at the Cowen 44th Annual Health..
22.2.202414:00GLOBECardiff Oncology to Report Fourth Quarter and Full Year 2023..
06.2.202422:01EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
17.1.202416:30PRNUSCardiff Oncology Announces Publication of Data from Phase 1b..
08.1.202415:12EDGAR2Form 8-K - Current report
20.11.202322:05PRNUSCardiff Oncology to Present at the 35th Annual Piper Sandler..
02.11.202321:06EDGAR2Form 8-K - Current report
02.11.202321:05PRNUSCardiff Oncology Reports Third Quarter 2023 Results and..
02.11.202321:02EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
26.10.202322:05PRNUSCardiff Oncology to Report Third Quarter 2023 Financial..
26.9.202322:07EDGAR2Form 8-K - Current report
26.9.202322:05PRNUSCardiff Oncology Announces Positive Clinical Data in..
05.9.202314:00PRNUSCardiff Oncology to Present at Upcoming Investor Conferences..
09.8.202322:06EDGAR2Form 8-K - Current report
09.8.202322:05PRNUSCardiff Oncology Reports Second Quarter 2023 Results and..
09.8.202322:01EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
07.8.202322:42EDGAR2Form 8-K - Current report
07.8.202322:05PRNUSCardiff Oncology Announces New Lead Program in First-Line..
24.7.202323:13EDGAR2Form 8-K - Current report
24.7.202323:09PRNUSCardiff Oncology Reports Inducement Grant Under Nasdaq..
20.6.202323:22PRNUSCardiff Oncology Reports Inducement Grant Under Nasdaq..
05.6.202314:00PRNUSCardiff Oncology to Present at the Jefferies Healthcare..
04.5.202322:10PRNUSCardiff Oncology Reports First-Quarter 2023 Results and..

Kürzlich von Ihnen besucht

Delayed Upgrade Clock